Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Lucas

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
The American Journal of Surgical Pathology|February 27, 2019
Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional OsteosarcomaKelsey E McHugh, John D Reith, David R Lucas, et al.
Journal of Pediatric Hematology/Oncology|August 4, 2012
Clear cell sarcoma of the jaw: a case report and review of the literatureSusumu Inoue, Douglas B Chepeha, David R Lucas, et al.
Oncotarget|August 17, 2016
A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcomaMelanie A Krook, Allegra G Hawkins, Rajiv M Patel, et al.
Rare Tumors|December 4, 2018
Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcomaLaurence M Briski, Dafydd G Thomas, Rajiv M Patel, et al.
Journal of Cutaneous Pathology|April 23, 2013
CD34-positive superficial myxofibrosarcoma: a potential diagnostic pitfallSteven C Smith, Ann A Poznanski, Douglas R Fullen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2012
Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcomaScott M Schuetze, Lili Zhao, Rashmi Chugh, et al.
The Oncologist|May 2, 2008
Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumorsHussein Tawbi, Dafydd Thomas, David R Lucas, et al.
BMC Cancer|August 22, 2016
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapyElizabeth J Davis, Lili Zhao, David R Lucas, et al.
The Oncologist|May 2, 2008
Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlationDavid R Lucas, Malti P Kshirsagar, J Sybil Biermann, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcomaMary Feng, James Murphy, Kent A Griffith, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
The American Journal of Surgical Pathology|February 27, 2019
Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional OsteosarcomaKelsey E McHugh, John D Reith, David R Lucas, et al.
Journal of Pediatric Hematology/Oncology|August 4, 2012
Clear cell sarcoma of the jaw: a case report and review of the literatureSusumu Inoue, Douglas B Chepeha, David R Lucas, et al.
Oncotarget|August 17, 2016
A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcomaMelanie A Krook, Allegra G Hawkins, Rajiv M Patel, et al.
Rare Tumors|December 4, 2018
Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcomaLaurence M Briski, Dafydd G Thomas, Rajiv M Patel, et al.
Journal of Cutaneous Pathology|April 23, 2013
CD34-positive superficial myxofibrosarcoma: a potential diagnostic pitfallSteven C Smith, Ann A Poznanski, Douglas R Fullen, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2012
Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced sarcomaScott M Schuetze, Lili Zhao, Rashmi Chugh, et al.
The Oncologist|May 2, 2008
Epidermal growth factor receptor expression and mutational analysis in synovial sarcomas and malignant peripheral nerve sheath tumorsHussein Tawbi, Dafydd Thomas, David R Lucas, et al.
BMC Cancer|August 22, 2016
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapyElizabeth J Davis, Lili Zhao, David R Lucas, et al.
The Oncologist|May 2, 2008
Histologic alterations from neoadjuvant chemotherapy in high-grade extremity soft tissue sarcoma: clinicopathological correlationDavid R Lucas, Malti P Kshirsagar, J Sybil Biermann, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2007
Long-term outcomes after radiotherapy for retroperitoneal and deep truncal sarcomaMary Feng, James Murphy, Kent A Griffith, et al.
Pageof 9